Kappa free light chains: Diagnostic and prognostic relevance in MS and CIS

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Presslauer, Stefan ^a   Milosavljevic, Dejan ^b   Huebl, Wolfgang ^b   Parigger, Silvia ^a   Schneider Koch, Gabriele ^a   Bruecke, Thomas ^a  

^a WILHELMINEN HOSPITAL   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; KAPPA FREE LIGHT CHAIN; UNCLASSIFIED DRUG; IMMUNOGLOBULIN KAPPA CHAIN;

ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD CEREBROSPINAL FLUID BARRIER; CELL ACTIVITY; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; ENCEPHALITIS; HUMAN; HUMORAL IMMUNITY; IMMUNOGLOBULIN PRODUCTION; LIMIT OF QUANTITATION; LYME DISEASE; MAJOR CLINICAL STUDY; MENINGITIS; MULTIPLE SCLEROSIS; PLASMA CELL; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; ADULT; DEMYELINATING DISEASES; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED;

ADULT; DEMYELINATING DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS;

EID: 84896121190     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089945     Document Type: Article

References (34)

1. Tintore M, Rovira A, Rio J, Tur C, Pelayo R et al. (2008) Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis? Neurology 70: 1079-1083. (Pubitemid 351464763)
2. Zipoli V, Hakiki B, Portaccio E, Lolli F, Siracusa G et al. (2009) The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis. Mult Scler 15: 472-478.
3. Schaffler N, Kopke S, Winkler L, Schippling S, Inglese M et al. (2011) Accuracy of diagnostic tests in multiple sclerosis-a systematic review. Acta Neurol Scand 124: 151-164.
4. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58: 840-846. (Pubitemid 41746873)
5. Reiber H, Ungefehr S, Jacobi C (1998) The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis. Mult Scler 4: 111-117. (Pubitemid 28410034)
6. Lefvert AK, Link H. (1985) IgG production within the central nervous system: a critical review of proposed formulae. Ann Neurol 17: 13-20. (Pubitemid 15156045)
7. McLean BN, Luxton RW, Thompson EJ (1990) A study of immunoglobulin G in the cerebrospinal fluid of 1007 patients with suspected neurological disease using isoelectric focusing and the Log IgG-Index. A comparison and diagnostic applications. Brain 113: 1269-1289. (Pubitemid 20385912)
8. Freedman MS, Thompson EJ, Deisenhammer F, Giovanonni G, Grimsley G et al. (2005) Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol 62: 865-870. (Pubitemid 40973448)
9. Link H, Huang YM (2006) Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 180: 17-28. (Pubitemid 44692326)
10. Dobson R, Ramagopalan S, Davis A, Giovannoni G (2013) Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude. J Neurol Neurosurg Psychiatry 84: 909-914.
11. Villar LM, Masjuan J, Sadaba MC, González-Porqué P, Plaza J et al. (2005) Early differential diagnosis of multiple sclerosis using a new oligoclonal band test. Arch Neurol 62: 574-577. (Pubitemid 40489888)
12. Rudick RA, French CA, Breton D, Williams GW (1989) Relative diagnostic value of cerebrospinal fluid kappa chains in MS: comparison with other immunoglobulin tests. Neurology 39: 964-968. (Pubitemid 19170423)
13. Krakauer M, Schaldemose Nielsen H, Jensen J, Sellebjerg F (1998) Intrathecal synthesis of free immunoglobulin light chains in multiple sclerosis. Acta Neurol Scand 98: 161-165. (Pubitemid 28435308)
14. Goffette S, Schluep M, Henry H, Duprez T, Sindic CJ (2004) Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis. J Neurol Neurosurg Psychiatry 75: 308-310. (Pubitemid 38183546)
15. Kaplan B, Aizenbud BM, Golderman S, Yaskariev R, Sela BA (2010) Free light chain monomers in the diagnosis of multiple sclerosis. J Neuroimmunol 229: 263-271.
16. Desplat-Jego S, Feuillet L, Pelletier J, Bernard D, Cherif AA, et al. (2005) Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry. J Clin Immunol 25: 338-345. (Pubitemid 41204258)
17. Presslauer S, Milosavljevic D, Brucke T, Bayer P, Hubl W (2008) Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J Neurol 255: 1508-1514.
18. Zeman AZ, Kidd D, McLean BN, Kelly MA, Francis DA et al. (1996) A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 60: 27-30. (Pubitemid 26013190)
19. Stendahl-Brodin L, Link H. (1980) Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 43: 102-105. (Pubitemid 10129581)
20. Joseph FG, Hirst CL, Pickersgill TP, Ben-Shlomo Y, Robertson NP et al. (2009) CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients. J Neurol Neurosurg Psychiatry 80: 292-296.
21. Annunziata P, Giorgio A, De Santi L, Zipoli V, Portaccio E et al. (2006) Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. J Neurol Sci 244: 97-102.
22. Siritho S, Freedman MS (2009) The prognostic significance of cerebrospinal fluid in multiple sclerosis. J Neurol Sci 279: 21-25.
23. Imrell K, Landtblom AM, Hillert J, Masterman T (2006) Multiple sclerosis with and without CSF bands: clinically indistinguishable but immunogenetically distinct. Neurology 67: 1062-1064. (Pubitemid 44454606)
24. Rojas JI, Patrucco L, Cristiano E (2010) Oligoclonal bands and MRI in clinically isolated syndromes: predicting conversion time to multiple sclerosis. J Neurol 257: 1188-1191.
25. Tintore M, Rovira A, Rio J, Otero S, Arrambide G et al. (2013) 1000 clinically isolated syndromes (CIS) : the 'Barcelona CIS inception cohort' ECTRIMS 2013, October 03;oral presentation;abstract online available.
26. Gout O, Bouchareine A, Moulignier A, Deschamps R, Papeix C et al. (2011) Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event. Mult Scler 17: 164-172.
27. Rudick RA, Medendorp SV, Namey M, Boyle S, Fischer J (1995) Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chains. Mult Scler 1: 150-155.
28. Rinker JR, 2nd, Trinkaus K, Cross AH (2006) Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology 67: 1288-1290. (Pubitemid 44563847)
29. Villar LM, Espino M, Costa-Frossard L, Muriel A, Jimenez J et al. (2012) High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis. Clin Chim Acta 413: 1813-1816.
30. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
31. Reiber H, Peter JB (2001) Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184: 101-122. (Pubitemid 32178265)
32. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF et al. (2002) Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 48: 1437-1444. (Pubitemid 34925779)
33. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA et al. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69: 292-302.
34. Miller DH, Weinshenker BG, Filippi M, Banwell BL, Cohen JA et al. (2008) Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler 14: 1157-1174.